Featured Research

from universities, journals, and other organizations

Antiprotons Four Times More Effective Than Protons For Cell Irradiation

Date:
November 2, 2006
Source:
CERN
Summary:
A pioneering experiment at CERN with potential future application in cancer therapy has produced its first results. Started in 2003, ACE (Antiproton Cell Experiment) is the first investigation of the biological effects of antiprotons.

The ACE experiment investigates the effect of antiprotons on cell irradiation. From left to right: Michael Holzscheiter with Niels Bassler and Helge Knudsen in front of the ACE experiment. The particle beam enters a tube of cells in the centre of a tank containing a solution of glycerol and water.
Credit: Image courtesy of CERN

A pioneering experiment at CERN with potential future application in cancer therapy has produced its first results. Started in 2003, ACE (Antiproton Cell Experiment) is the first investigation of the biological effects of antiprotons.

"We have taken the first step towards a novel treatment for cancer. The results show that antiprotons are four times more effective than protons at terminating live cells. Although it still has to be compared with other existing methods, it is a breakthrough in this area of investigation." says Michael Doser at CERN, one of the scientists collaborating on the experiment. ACE brings together a team of experts in the fields of physics, biology, and medicine from 10 institutes around the world.

Current particle beam therapy commonly uses protons to destroy tumour cells inside a patient. The ACE experiment directly compared the effectiveness of cell irradiation using protons and antiprotons. To simulate a cross-section of tissue inside a body, tubes were filled with hamster cells suspended in gelatine. Researchers sent a beam of protons or antiprotons with a range of 2 cm depth into one end of the tube, and evaluated the fraction of surviving cells after irradiation along the path of the beam.

The results showed that antiprotons were four times more effective than protons. When comparing a beam of antiprotons with a beam of protons that cause identical damage at the entrance to the target, the experiment found the damage to cells inflicted at the end of the beam path to be four times higher for antiprotons than for protons. Michael Holzscheiter, spokesperson of the ACE experiment, summarises: "To achieve the same level of damage to cells at the target area one needs four times fewer antiprotons than protons. This significantly reduces the damage to the cells along the entrance channel of the beam for antiprotons compared to protons. Due to the antiproton's unsurpassed ability to preserve healthy tissue while causing damage to a specific area, this type of beam could be highly valuable in treating cases of recurring cancer, where this property is vital."

Antiprotons are antimatter; they have to be produced in small amounts in a laboratory with the help of a particle accelerator. When matter and antimatter particles meet, they annihilate, or destroy each other, transforming their mass into energy. The experiment makes use of this property as the antiproton would annihilate with a part of the nucleus of an atom in a tumour cell. The fragments produced from the energy released by the annihilation would be projected into adjacent tumour cells, which are in turn destroyed.

"CERN is a unique facility for this work. It is the only place in the world where an antiproton beam of sufficiently low energy and high quality is available. This is crucial for our research. Without access to the antiproton decelerator facility, these experiments would simply not have been possible." says Niels Bassler, co-spokesperson of ACE. "This experiment is a fantastic example of how research in particle physics can generate innovative solutions with potential medical benefits."

Researchers are currently conducting more tests to irradiate cells at a greater depth (about 15cm below the surface). Experiments to compare the effectiveness of antiprotons with another form of treatment using carbon ions will begin next month at GSI (Gesellschaft fόr Schwerionenforschung) in Germany. Further tests are planned to fully assess the effectiveness and suitability of antiprotons for cancer therapy, and to assure that less damage is caused to healthy tissues compared to other methods.

If all goes well, the first clinical application would still be a decade or more into the future.

Full results of the experiment are published today in Radiotherapy and Oncology -- Journal of the European Society for Therapeutic Radiology and Oncology. Holzscheiter MH et al., The Biological Effectiveness of Antiproton Irradiation, Radiother Oncol (2006), doi:10.1016/j.radonc.2006.09.012


Story Source:

The above story is based on materials provided by CERN. Note: Materials may be edited for content and length.


Cite This Page:

CERN. "Antiprotons Four Times More Effective Than Protons For Cell Irradiation." ScienceDaily. ScienceDaily, 2 November 2006. <www.sciencedaily.com/releases/2006/10/061031141340.htm>.
CERN. (2006, November 2). Antiprotons Four Times More Effective Than Protons For Cell Irradiation. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2006/10/061031141340.htm
CERN. "Antiprotons Four Times More Effective Than Protons For Cell Irradiation." ScienceDaily. www.sciencedaily.com/releases/2006/10/061031141340.htm (accessed September 16, 2014).

Share This



More Matter & Energy News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Space Race Pits Bezos Vs Musk

Space Race Pits Bezos Vs Musk

Reuters - Business Video Online (Sep. 16, 2014) — Amazon CEO Jeff Bezos' startup will team up with Boeing and Lockheed to develop rocket engines as Elon Musk races to have his rockets certified. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Manufacturer Prints 3-D Car In Record Time

Manufacturer Prints 3-D Car In Record Time

Newsy (Sep. 15, 2014) — Automobile manufacturer Local Motors created a drivable electric car using a 3-D printer. Printing the body only took 44 hours. Video provided by Newsy
Powered by NewsLook.com
Refurbished New York Subway Tunnel Unveiled After Sandy Damage

Refurbished New York Subway Tunnel Unveiled After Sandy Damage

Reuters - US Online Video (Sep. 15, 2014) — New York officials unveil subway tunnels that were refurbished after Superstorm Sandy. Nathan Frandino reports. Video provided by Reuters
Powered by NewsLook.com
Frustration As Drone Industry Outpaces Regulation In U.S.

Frustration As Drone Industry Outpaces Regulation In U.S.

Newsy (Sep. 14, 2014) — U.S. firms worry they’re falling behind in the marketplace as the FAA considers how to regulate commercial drones. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:  

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile iPhone Android Web
      Follow Facebook Twitter Google+
      Subscribe RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins